Ceros Capital Markets

GT Metabolic Solutions focuses on developing innovative gastrointestinal devices aimed at enhancing bariatric, metabolic, and digestive surgeries. The company's technology enables minimally invasive procedures by utilizing a magnetic connection within the gastrointestinal tract. This approach offers medical professionals a less invasive alternative to traditional surgical methods, potentially improving patient outcomes and recovery times. By prioritizing incision-less techniques, GT Metabolic Solutions is positioned to make significant advancements in gastroenterology, addressing the growing need for effective and less traumatic surgical options.

DermaSensor, Inc. is a Miami-based company that develops a handheld device designed to evaluate skin lesions for cancer using artificial intelligence and spectroscopy. Founded in 2009, the company's flagship product enables both physicians and consumers to conduct skin checks conveniently in clinical settings and at home. The device employs elastic scattering spectroscopy and machine learning algorithms to rapidly assess skin lesions, helping to identify potential cancerous cells. By providing an affordable and efficient tool for early detection, DermaSensor aims to improve access to skin cancer evaluations, addressing the significant number of Americans who have never undergone such checks. The technology not only facilitates immediate assessments but also alerts users when cancerous cells are detected, streamlining the process of skin cancer diagnostics.

Pristine Surgical LLC, founded in 2011 and based in Manchester, New Hampshire, has developed a groundbreaking single-use digital imaging platform tailored for surgical and diagnostic rigid endoscopic procedures. The company specializes in single-use digital arthroscopes and laparoscopes that come in a completely sterile kit. By integrating high-definition digital imaging, advanced LED lighting, artificial intelligence, and cloud-based software, Pristine Surgical aims to enhance the efficiency and safety of over 23 million procedures annually. The platform not only improves the surgical experience for patients and healthcare providers but also addresses key concerns such as cost reduction, risk mitigation, and the elimination of cross-contamination associated with reprocessing instruments. Through its innovative technology, Pristine Surgical strives to streamline the entire surgical episode, ultimately improving communication and satisfaction among surgeons and healthcare facilities.

Pathology Watch Inc. is a company based in Salt Lake City, Utah, that specializes in providing remote specimen interpretation services to hospitals, laboratories, and dermatology centers through its digital pathology solution. Founded in 2017, the company collaborates with dermatopathologists and sub-specialized pathologists to interpret digital slides, pathology reports, and biopsy slides. Additionally, Pathology Watch offers telepathology services, facilitating large clinics and hospitals in enhancing their pathology workflows. By digitizing these processes, the company aims to improve patient care quality, reduce costs, and create new revenue opportunities for healthcare providers.